Compare drug alternatives
Aimovig® Alternatives
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Emgality®
- Vyepti®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Ajovy®
(Fremanezumab)
Ajovy
-
Migraine
- Emgality®
- Vyepti®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Ajovy is a prescription medication that can be self-injected once a month or once every three months under the skin to prevent migraine headaches. The most commonly reported side effect is injection site reactions. Ajovy does not seem to cause constipation. Additionally, there are no known drug interactions.
Ajovy is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Subcutaneous
Subcutaneous
Dosing
70 mg once monthly or 140 mg once monthly (for some patients)
225 mg monthly or 675 mg every 3 months (as three consecutive injections of 225 mg each)
Latin Shorthand
70 mg/mo or 140 mg/mo
225 mg/mo or 675 mg q3mo
Financial Assistance
Copay
$5
$5
Annual Cap
Patient specific maximum benefit.
Patient specific maximum benefit.
Assistance Expiration
Calendar year
12/31/2023
Generics
No lower-cost generic available
No lower-cost generic available